Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
04/08/2026 15:50
BRIEF-Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803 Aug 4 (Reuters) - Entropy Neurodynamics Ltd ENP.AX:
ENTROPY NEURODYNAMICS - SECURES HREC APPROVAL FOR PHASE 1B/2A 8-INDICATION BASKET STUDY OF TRP-8803
ENTROPY NEURODYNAMICS - TO EVALUATE TRP-8803 ACROSS EIGHT MAJOR DISORDERS IN SINGLE CLINICAL FRAMEWORK
ENTROPY NEURODYNAMICS - PATIENT RECRUITMENT TO COMMENCE, FIRST DOSING EXPECTED LATER THIS QUARTER
ENTROPY NEURODYNAMICS - DOSING IN INITIAL COHORTS ANTICIPATED BEFORE END OF CY2026
ENTROPY NEURODYNAMICS - ENTERS CLINICAL TRIAL RESEARCH AGREEMENT WITH SWINBURNE UNIVERSITY FOR WORLD-FIRST TRIAL
Source text: ID:nPn45fWDQa
Further company coverage: ENP.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Entropy Neurodynamics
See all newsBrief: Entropy Neurodynamics Seeks Trading Halt
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt